|
|
|
|
Дата |
|---|
| 27.08.2026 |
| 25.08.2026 |
| 24.08.2026 |
| 23.08.2026 |
| 20.08.2026 |
| 19.08.2026 |
| 18.08.2026 |
| 17.08.2026 |
| 16.08.2026 |
| 13.08.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
131.50
|
130.25
|
133.80
|
131.20
|
|
|
98 289 939.94
|
2 448.00
|
|
|
|
133.82
|
130.50
|
135.00
|
131.50
|
|
|
138 726 076.38
|
3 229.00
|
|
|
|
138.12
|
133.50
|
141.00
|
133.82
|
|
|
269 767 656.38
|
4 456.00
|
|
|
|
131.50
|
132.01
|
139.90
|
138.12
|
|
|
448 855 783.79
|
7 731.00
|
|
|
|
129.16
|
128.10
|
133.99
|
131.50
|
|
|
241 171 147.30
|
4 910.00
|
|
|
|
134.30
|
128.52
|
135.97
|
129.16
|
|
|
243 878 173.24
|
6 008.00
|
|
|
|
137.00
|
134.03
|
141.00
|
134.30
|
|
|
256 337 165.63
|
5 754.00
|
|
|
|
137.01
|
135.01
|
147.00
|
137.00
|
|
|
658 931 395.49
|
10 828.00
|
|
|
|
143.00
|
137.01
|
145.20
|
137.01
|
|
|
328 503 268.88
|
7 537.00
|
|
|
|
142.51
|
141.11
|
155.00
|
143.00
|
|
|
447 594 757.07
|
7 591.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2020, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2012, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
26.04.2026
|
27.04.2026 |
3.5 EGP |
|
13.04.2023
|
18.04.2023 |
2 EGP |
|
21.04.2021
|
25.04.2021 |
2.95 EGP |
|
02.05.2019
|
05.05.2019 |
4 EGP |
|
06.04.2018
|
10.04.2018 |
4.5 EGP |
|
08.05.2017
|
09.05.2017 |
3.5 EGP |
|
21.04.2016
|
24.04.2016 |
3.5 EGP |
|
23.04.2013
|
24.04.2013 |
3 EGP |
|
24.05.2012
|
27.05.2012 |
3 EGP |
|
29.04.2011
|
02.05.2011 |
2.5 EGP |
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets
